首页> 外文期刊>Journal of Neuro-Oncology >Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells
【24h】

Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells

机译:1-(4-氨基-2-甲基-5-嘧啶基)-甲基-3-(2-氯乙基)-3-亚硝基脲(ACNU)耐药C6大鼠神经胶质瘤细胞的基因表达谱

获取原文
获取原文并翻译 | 示例
           

摘要

Chemotherapy in itself is suspected to cause the development or selection of drug-resistant tumor cells, which have more aggressive phenotypes. The authors investigated the differential changes of gene expression in the 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant subline of the C6 rat glioma (C6AR2), which was established from C6 rat glioma cells by exposure to ACNU in vitro. The resistance to ACNU of C6AR2 was confirmed by MTS assay. The increased expression of O 6-methylguanine-DNA methyltransferase in C6AR2 cells was shown using RT-PCR. C6AR2 cells displayed a higher proliferative activity relative to C6 cells. Analysis with cDNA array showed that 19 genes were transcriptionally up-regulated and 16 genes down-regulated in C6AR2 cells compared to C6 cells. They belonged to various functional classes of genes beside the drug-resistant system. Among them, the down-regulation of several genes in C6AR2 cells, including c-kit, pleiotrophin, platelet-derived growth factor receptor-α, peripheral myelin protein-22 and NG2 chondroitin sulfate proteoglycan, which are expressed originally in developmental glial linages, were verified using semi-quantitative RT-PCR. In addition, the gene expression of astroglial intermediate filament proteins, including GFAP, vimentin and nestin, were decreased in C6AR2 cells relative to C6 cells in semi-quantitative RT-PCR and immunocytochemistry. These findings may represent an undifferentiated state of ACNU-resistant glioma cells and a more aggressive phenotype in recurrent tumors following chemotherapy.
机译:怀疑化学疗法本身会引起耐药性肿瘤细胞的发展或选择,而耐药性肿瘤细胞具有更具攻击性的表型。作者研究了C6大鼠的1-(4-氨基-2-甲基-5-嘧啶基)-甲基-3-(2-氯乙基)-3-亚硝基脲(ACNU)耐药亚系中基因表达的差异变化胶质瘤(C6AR2),是通过在体外暴露于ACNU从C6大鼠胶质瘤细胞中建立的。通过MTS分析证实了C6AR2对ACNU的抗性。 RT-PCR显示O6 -甲基鸟嘌呤-DNA甲基转移酶在C6AR2细胞中表达增加。相对于C6细胞,C6AR2细胞表现出更高的增殖活性。 cDNA阵列分析显示,与C6细胞相比,C6AR2细胞中有19个基因在转录上被上调,而16个基因在C6AR2细胞中被下调。它们属于耐药系统之外的各种功能基因。其中,C6AR2细胞中几个基因的下调,包括c-kit,多卵磷脂,血小板衍生的生长因子受体-α,外周血髓鞘蛋白22和NG2硫酸软骨素蛋白聚糖,这些基因最初在发育的神经胶质细胞系中表达,使用半定量RT-PCR进行了验证。另外,在半定量RT-PCR和免疫细胞化学中,相对于C6细胞,星形胶质中间丝蛋白(包括GFAP,波形蛋白和巢蛋白)的基因表达相对于C6细胞降低了。这些发现可能代表了化疗后复发肿瘤中ACNU耐药神经胶质瘤细胞的未分化状态和更具攻击性的表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号